Upgrade to SI Premium - Free Trial

Generic EpiPen to Hit Mylan (MYL) EPS by a Modest 2% - Leerink

August 29, 2016 10:08 AM
Leerink Partners analyst Jason Gerberry weighed in on Mylan (NASDAQ: MYL) after the company announced the launch of a generic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View

Next Articles